Unknown

Dataset Information

Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma.


ABSTRACT:

Objective

This analysis was performed to assess whether antiepileptic drugs (AEDs) modulate the effectiveness of temozolomide radiochemotherapy in patients with newly diagnosed glioblastoma.

Methods

The European Organization for Research and Treatment of Cancer (EORTC) 26981-22981/National Cancer Institute of Canada (NCIC) CE.3 clinical trial database of radiotherapy (RT) with or without temozolomide (TMZ) for newly diagnosed glioblastoma was examined to assess the impact of the interaction between AED use and chemoradiotherapy on survival. Data were adjusted for known prognostic factors.

Results

When treatment began, 175 patients (30.5%) were AED-free, 277 (48.3%) were taking any enzyme-inducing AED (EIAED) and 135 (23.4%) were taking any non-EIAED. Patients receivin

SUBMITTER: Weller M 

PROVIDER: S-EPMC3265044 | biostudies-literature | 2011 Sep

REPOSITORIES: biostudies-literature